Effects of repeated morphine treatment on the antinociceptive effects, intestinal absorption, and efflux from intestinal epithelial cells of morphine

Biological and Pharmaceutical Bulletin

Volumn 32, Issue 9, 2009, Pages 1571-1575

  Okura, Takashi ^a,b   Ozawa, Tadahiro ^a   Ibe, Michiko ^a   Taki, Yuko ^a   Kimura, Midori ^a   Kagawa, Yoshiyuki ^a   Kato, Yoshihisa ^a,c   Yamada, Shizuo ^a  

^a UNIVERSITY OF SHIZUOKA   (Japan)

^b TEIKYO UNIVERSITY   (Japan)

^c TOKUSHIMA BUNRI UNIVERSITY   (Japan)

Author keywords

Absorption; Morphine; P glycoprotein; Tolerance

Indexed keywords

GLYCOPROTEIN P; MORPHINE; RHODAMINE 123; VINCRISTINE;

ANTINOCICEPTION; ARTICLE; CELL MEMBRANE PERMEABILITY; CELL STRAIN CACO 2; CONTROLLED STUDY; DRUG ABSORPTION; DRUG EFFECT; DRUG PENETRATION; HUMAN; HUMAN CELL; INTESTINE ABSORPTION; INTESTINE EPITHELIUM CELL; MALE; NONHUMAN; RAT;

ANALGESICS, OPIOID; ANIMALS; CACO-2 CELLS; CELL MOVEMENT; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; HUMANS; INTESTINAL ABSORPTION; INTESTINAL MUCOSA; INTESTINE, SMALL; MALE; MORPHINE; PAIN MEASUREMENT; RATS; RATS, SPRAGUE-DAWLEY;

EID: 69949139346     PISSN: 09186158     EISSN: 13475215     Source Type: Journal    
DOI: 10.1248/bpb.32.1571     Document Type: Article

References (22)

1. Okura T., Yamada S., Kimura R., Recent Res. Devel. Drug Metab. Dispos., 1, 101-105 (2002).
2. Kharasch E. D., Hoffer C., Whittington D., Sheffels P., Clin. Pharmacol. Ther., 74, 543-554 (2003).
3. Schinkel A. H., Wagenaar E., van Deemter L., Mol C. A., Borst P., J. Clin. Invest., 96, 1698-1705 (1995).
4. Xie R., Hammarlund-Udenaes M., de Boer A. G., de Lange E. C., Br. J. Pharmacol., 128, 563-568 (1999).
5. Letrent S. P., Pollack G. M., Brouwer K. R., Brouwer K. L., Drug Metab. Dispos., 27, 827-834 (1999).
6. Zong J., Pollack G. M., Pharm. Res., 17, 749-753 (2000).
7. Aquilante C. L., Letrent S. P., Pollack G. M., Brouwer K. L., Life Sci., 66, PL47-PL51 (2000).
8. King M., Su W., Chang A., Zuckerman A., Pasternak G. W., Nat. Neurosci., 4, 268-274 (2001).
9. Yousif S., Saubaméa B., Cisternino S., Marie-Claire C., Dauchy S., Scherrmann J. M., Declèves X., J. Neurochem., 107, 647-657 (2008).
10. Okura T., Ozawa T., Ito Y., Kimura M., Kagawa Y., Yamada S., Biol. Pharm. Bull., 31, 2338-2341 (2008).
11. Okura T., Morita Y., Ito Y., Kagawa Y., Yamada S., J. Pharm. Pharmacol., 61, 593-597 (2009).
12. Mao J., Price D. D., Caruso F. S., Mayer D. J., Pain, 67, 361-368 (1996).
13. Parkitna J. R., Obara I., Wawrzczak-Bargiela A., Makuch W., Przewlocka B., Przewlocki R., J. Pharmacol. Exp. Ther., 319, 832-839 (2006).
14. Levine R. R., Pelikan E. W., J. Pharmacol. Exp. Ther., 131, 319-327 (1961).
15. Takara K., Tsujimoto M., Ohnishi N., Yokoyama T., Biochem. Biophys. Res. Commun., 292, 190-194 (2002).
16. Venn R., Michalkiewicz A., J. Chromatogr., 525, 379-388 (1990).
17. Okura T., Saito M., Nakanishi M., Komiyama N., Fujii A., Yamada S., Kimura R., Br. J. Pharmacol., 140, 211-217 (2003).
18. Patrick G. A., Dewey W. L., Huger F. P., Daves E. D., Harris L. S., J. Pharmacol. Exp. Ther., 205, 556-562 (1978).
19. Tan T., Kuramoto M., Takahashi T., Nakamura H., Nakanishi Y., Imasato Y., Yoshimura H., Chem. Pharm. Bull., 37, 168-173 (1989).
20. Yamashita S., Tanaka Y., Endoh Y., Taki Y., Sakane T., Nadai T., Sezaki H., Pharm. Res., 14, 486-491 (1997).
21. Hosoya K., Kim K. J., Lee V. H., Pharm. Res., 13, 885-890 (1996).
22. McQuay H. J., Carroll D., Faura C. C., Gavaghan D. J., Hand C. W., Moore R. A., Clin. Pharmacol. Ther., 48, 236-244 (1990).